Literature DB >> 18952270

Preoperative pathologic findings associated with residual disease at radical hysterectomy in women with stage IA2 cervical cancer.

Anuj Suri1, Michael Frumovitz, Michael R Milam, Ricardo dos Reis, Pedro T Ramirez.   

Abstract

OBJECTIVE: To correlate findings on pathologic examination of loop electroexcisional procedure (LEEP) or cone biopsy specimens with residual disease in radical hysterectomy specimens in patients with stage IA2 cervical cancer to determine whether a subset of such patients may be eligible for conservative, fertility-sparing treatment.
METHODS: We performed a retrospective chart review of patients diagnosed with stage IA2 cervical cancer who had undergone LEEP or cone biopsy before radical hysterectomy. Surgicopathologic features of LEEP and cone biopsy specimens were correlated with the presence or absence of residual tumor in radical hysterectomy specimens.
RESULTS: Forty-two patients met the inclusion criteria. At radical hysterectomy, 22 patients (52%) had no residual tumor, while 20 patients (48%) had residual disease. Margin status was the only statistically significant predictor of the presence or absence of residual disease at radical hysterectomy; positive margins predicted the presence of residual disease (P<0.001).
CONCLUSION: Women with stage IA2 cervical cancer and negative margins on LEEP or cone biopsy specimens should be counseled that they may be at low risk for having residual disease in the final radical hysterectomy specimen.

Entities:  

Mesh:

Year:  2008        PMID: 18952270      PMCID: PMC4361069          DOI: 10.1016/j.ygyno.2008.09.011

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  15 in total

1.  FIGO staging classifications and clinical practice guidelines in the management of gynecologic cancers. FIGO Committee on Gynecologic Oncology.

Authors:  J L Benedet; H Bender; H Jones; H Y Ngan; S Pecorelli
Journal:  Int J Gynaecol Obstet       Date:  2000-08       Impact factor: 3.561

2.  Influence of quantity of lymph-vascular space invasion on the risk of nodal metastases in women with early-stage squamous cancer of the cervix.

Authors:  L D Roman; J C Felix; L I Muderspach; T Varkey; A F Burnett; D Qian; C P Morrow
Journal:  Gynecol Oncol       Date:  1998-03       Impact factor: 5.482

3.  How important is removal of the parametrium at surgery for carcinoma of the cervix?

Authors:  A Covens; B Rosen; J Murphy; S Laframboise; A D DePetrillo; G Lickrish; T Colgan; W Chapman; P Shaw
Journal:  Gynecol Oncol       Date:  2002-01       Impact factor: 5.482

Review 4.  Vaginal radical trachelectomy: a valuable fertility-preserving option in the management of early-stage cervical cancer. A series of 50 pregnancies and review of the literature.

Authors:  Marie Plante; Marie-Claude Renaud; Iffath A Hoskins; Michel Roy
Journal:  Gynecol Oncol       Date:  2005-07       Impact factor: 5.482

5.  Conservative management of adenocarcinoma in situ of the cervix.

Authors:  C H Shin; J O Schorge; K R Lee; E E Sheets
Journal:  Gynecol Oncol       Date:  2000-10       Impact factor: 5.482

6.  A prospective surgical pathological study of stage I squamous carcinoma of the cervix: a Gynecologic Oncology Group Study.

Authors:  G Delgado; B N Bundy; W C Fowler; F B Stehman; B Sevin; W T Creasman; F Major; P DiSaia; R Zaino
Journal:  Gynecol Oncol       Date:  1989-12       Impact factor: 5.482

7.  Is conservative treatment for adenocarcinoma in situ of the cervix safe?

Authors:  W P Soutter; D Haidopoulos; R J Gornall; G A McIndoe; J Fox; W P Mason; A Flanagan; N Nicholas; F Barker; J Abrahams; I Lampert; P Sarhanis
Journal:  BJOG       Date:  2001-11       Impact factor: 6.531

8.  Initial experience with Dargent's operation: the radical vaginal trachelectomy.

Authors:  Y Sonoda; D S Chi; J Carter; R R Barakat; N R Abu-Rustum
Journal:  Gynecol Oncol       Date:  2007-11-08       Impact factor: 5.482

9.  Preoperative lymph-vascular space invasion is associated with nodal metastases in women with early-stage cervical cancer.

Authors:  Michael R Milam; Michael Frumovitz; Ricardo dos Reis; Russell R Broaddus; Roland L Bassett; Pedro T Ramirez
Journal:  Gynecol Oncol       Date:  2007-05-10       Impact factor: 5.482

Review 10.  Conservative surgical methods for FIGO stage IA2 squamous cervical carcinoma and their role in preserving women's fertility.

Authors:  George Koliopoulos; Alexandros Sotiriadis; Maria Kyrgiou; Pierre Martin-Hirsch; George Makrydimas; Evangelos Paraskevaidis
Journal:  Gynecol Oncol       Date:  2004-05       Impact factor: 5.482

View more
  5 in total

1.  Predictive Factors for Residual Disease After Conization in Cervical Cancer.

Authors:  Glauco Baiocchi; Thiago Pereira Diniz; Graziele Bovolim; Bruna Tirapelli Gonçalves; Lillian Yuri Kumagai; Henrique Mantoan; Carlos Chaves Faloppa; Andrea Paiva Gadelha Guimaraes; Alexandre Andre Balieiro Anastacio da Costa; Levon Badiglian-Filho; Louise De Brot
Journal:  Ann Surg Oncol       Date:  2021-02-10       Impact factor: 5.344

Review 2.  Fertility-Sparing Options in Young Women with Cervical Cancer.

Authors:  Federica Tomao; Giacomo Corrado; Fedro Alessandro Peccatori; Sara Boveri; Eleonora Petra Preti; Nicoletta Colombo; Fabio Landoni
Journal:  Curr Treat Options Oncol       Date:  2016-01

3.  Occult invasive cervical cancer after simple hysterectomy: a multi-center retrospective study of 89 cases.

Authors:  Huimin Bai; Dongyan Cao; Fang Yuan; Huilan Wang; Jie Chen; Yue Wang; Keng Shen; Zhenyu Zhang
Journal:  BMC Cancer       Date:  2016-07-20       Impact factor: 4.430

4.  Machine learning methods to predict presence of residual cancer following hysterectomy.

Authors:  Reetam Ganguli; Jordan Franklin; Xiaotian Yu; Alice Lin; Daithi S Heffernan
Journal:  Sci Rep       Date:  2022-02-17       Impact factor: 4.379

5.  Accuracy of conization procedure for predicting pathological parameters of radical hysterectomy in stage Ia2-Ib1 (≤2 cm) cervical cancer.

Authors:  Huimin Bai; Dongyan Cao; Fang Yuan; Huilan Wang; Meizhu Xiao; Jie Chen; Quancai Cui; Keng Shen; Zhenyu Zhang
Journal:  Sci Rep       Date:  2016-05-16       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.